U.S. market Closed. Opens in 3 hours 18 minutes

INM | InMed Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-07-312003-07-312002-07-312001-07-31
Revenue4.60M4.14M1.09MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A39.66K79.46K168.42K623.37K1.74M2.76M4.23M2.09M185.61K13.77K2.44K
Cost of Revenue3.50M2.73M545.89K197.03K183.09K93.94K92.78KN/AN/AN/AN/AN/AN/AN/A8.76K108.89K405.58K1.82M1.42M3.19M1.20M90.02K17.16K17.02K
Gross Profit1.10M1.40M543.55K-197.03K-183.09K-93.94K-92.78KN/AN/AN/AN/AN/AN/A39.66K70.71K59.53K217.79K-80.56K1.34M1.04M892.20K95.59K-3.39K-14.58K
Operating Expenses9.02B9.78M14.34M9.94M8.87M10.39M6.69M3.44M1.84M3.46M1.15M46.75K168.60K427.21K482.11K836.53K1.49M1.69M2.52M3.03M2.13M1.38M2.75M4.24M
Selling, General & Admin5.25M5.85M6.87M4.48M3.50M6.00M5.17M2.79M1.48M2.62M1.09M46.75K151.57K314.36K300.73K536.37K1.17M1.31M2.26M2.58M1.84M995.66K902.67K3.91M
Research & Development3.77M3.73M7.28M5.34M5.20M4.30M1.52M573.72K292.84K759.85K57.87KN/A17.03KN/A118.42K116.94K236.23K212.64KN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/A-308.94K185.66K120.87K161.97K94.72K075.22K67.41K75.76K-900.00N/AN/A-73.79K-104.25K237.90K83.24K169.63K255.18K453.18K295.85K380.70K1.85M329.67K
Operating IncomeN/A-8.18B-13.70M-9.92M-8.74M-10.36M-6.78M-3.44M-1.84M-3.45M-1.15M-49.19K-168.72K-387.56K-411.40K-777.00K-1.27M-1.77M-1.18M-1.99M-1.24M-1.28M-2.75M-4.25M
Other Expenses / Income246.38M588.53K-1.10M2.12M60.73K262.10K69.77K-495.00-47.00-3.52K-1.69K2.45K-21.20K-73.79K-104.25K-276.94K-230.10K-17.47K-20.14K-760.73K-267.57K543.00-32.91K1.96M
Before Tax Income-7.67M-7.93M-18.60M-10.20M-8.68M-10.10M-6.71M-3.44M-1.84M-3.46M-1.15M-46.74K-189.91K-461.35K-515.65K-1.05M-1.50M-1.79M-1.20M-2.75M-1.51M-1.28M-2.79M-2.29M
Income Tax Expenses7.10K13.10K4.81M360.35K18.62K-262.10K-69.54K495.0047.003.52K1.69K-2.46K21.18K-73.79K-104.25K791.78K-347.85K99.59K99.26K816.12K277.22K-50.37K-40.34K15.51K
Net Income-7.68M-7.95M-18.60M-10.20M-8.94M-10.01M-6.71M-3.44M-1.84M-3.46M-1.15M-46.74K-189.91K-325.47K-334.79K-1.06M-922.26K-1.87M-1.27M-2.78M-1.52M-1.23M-2.71M-4.27M
Interest ExpensesN/AN/A96.09K360.35K18.62KN/AN/A495.0047.003.52K1.69K10.0016.0011.70K27.63K5.90K230.10K17.47K20.14K760.73K267.57KN/A32.91KN/A
Basic Shares Outstanding7.59M2.45M560.75K270.00K210.00K210.00K172.67K108.43K72.97K55.87K41.93K40.84K40.84K17.43K4.70K3.78K3.39K2.55K1.76K1.07K13.60K3.67K3.67K3.67K
Diluted Shares Outstanding7.59M2.45M560.83K270.00K210.00K210.00K172.67K108.43K72.97K55.87K41.93K40.84K40.84K17.43K4.70K3.78K3.41K2.64K1.76K1.07K13.60K3.67K3.67K3.67K
EBITDA-7.06M-10.83M-17.26M-9.80M-8.58M-10.26M-6.69M-3.36M-1.77M-3.38M-1.15M-46.75K-168.59K-252.04K-341.90K-608.24K-1.19M-973.42K-920.79K-1.54M-946.79K-900.07K-906.07K-2.04M
EBITDA Margin-153.64%-261.92%-1,584.07%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-635.53%-430.26%-361.14%-190.39%-56.04%-33.39%-36.29%-45.25%-484.92%-6,580.49%-83,382.55%
EBIT-7.67M-7.93M-13.70M-9.48M-8.90M-10.27M-6.78M-3.44M-1.84M-3.45M-1.15M-49.19K-168.72K-387.56K-411.40K-262.15K-1.04M-1.76M-1.15M-1.20M-975.08K-1.28M-2.72M-4.25M
EBIT Margin-166.79%-191.86%-1,257.13%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-977.25%-517.73%-155.65%-166.84%-101.16%-41.81%-28.39%-46.60%-690.02%-19,750.54%-174,116.00%
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-07-312003-07-312002-07-312001-07-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙